VivoSim Labs Inc.

NASDAQ: VIVS · Real-Time Price · USD
1.80
-0.01 (-0.55%)
At close: Aug 15, 2025, 12:39 PM

VivoSim Labs Balance Sheet Statement

Financials in USD. Fiscal year is April - March.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Mar 31, 2025 Mar 31, 2024 Mar 31, 2023 Mar 31, 2022
Cash & Equivalents
11.31M 2.9M 15.3M 28.68M
Short-Term Investments
n/a n/a 706K n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
1.23M 445K 658K 948K
Receivables
30K 33K 152K n/a
Inventory
n/a 297K n/a n/a
Other Current Assets
12K 4K 69K n/a
Total Current Assets
12.13M 3.94M 17.05M 29.53M
Property-Plant & Equipment
1.29M 1.97M 2.61M 2.81M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
2.52M 2.41M 3.27M 3.76M
Total Assets
14.65M 6.35M 20.31M 33.3M
Account Payables
1.64M 627K 331K 415K
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
n/a n/a n/a n/a
Other Current Liabilities
998K 536K 609K 434K
Total Current Liabilities
3.74M 1.86M 3.67M 1.38M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
421K 888K 1.31M 1.7M
Total Liabilities
4.16M 2.75M 4.98M 3.09M
Total Debt
942K 1.39M 1.8M 2.18M
Common Stock
2K 10K 9K 9K
Retained Earnings
-342.16M -339.67M -325M -307.74M
Comprehensive Income
n/a n/a 2K n/a
Shareholders Equity
10.49M 3.6M 15.33M 30.21M
Total Investments
n/a n/a 706K n/a